Abstract
Modifiable risk factors for cardiovascular disease were assessed among individuals with schizophrenia receiving continuous (i.e. 24-h) medical care. Participants tended to have higher levels of risk factors than for the general population. They had similar levels of risk factors as for previous UK studies of patients not receiving continuous care, except they tended to have higher smoking rates and lower physical activity levels, although statistical comparisons were not possible. Among patients with schizophrenia receiving continuous medical care interventions for health behavior change may need to be further prioritized and there is a need to capitalize on the ready availability of social support in these settings.
This is a preview of subscription content, log in via an institution to check access.
References
Allgöwer, A., Wardle, J., & Steptoe, A. (2001). Depressive symptoms, social support, and personal health behaviors in young men and women. Health Psychology, 20, 223–227.
Bai, Y. M., Chen, T. T., Yang, W. S., Chi, Y. C., Lin, C. C., Liou, Y. J., et al. (2009). Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: A cohort study. Schizophrenia Research, 111, 1–8.
Blair, S. N., Haskell, W. L., Ho, P., Paffenbarger, R. S., Jr., Vranizan, K. M., Farquhar, J. W., et al. (1985). Assessment of habitual physical activity by seven-day recall in a community survey and controlled experiments. American Journal of Epidemiology, 122, 794–804.
Bradshaw, T., Lovell, K., & Harris, N. (2005). Healthy living interventions and schizophrenia: A systematic review. Journal of Advanced Nursing, 49, 634–654.
British Cardiac Society, British Hypertension Society, HEART UK, Diabetes UK, Primary Care Cardiovascular Society, & Stroke Association. (2005). Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart, 91(suppl. 5), s1–s52.
Brown, S., Birtwistle, J., Roe, L., & Thompson, C. (1999). The unhealthy lifestyle of people with schizophrenia. Psycholological Medicine, 29, 697–701.
Craig, R., & Mindell, J. (2008). Health Survey for England 2006 (Vol. 1): Cardiovascular disease and risk factors in adults. Leeds: The Information Centre.
Craig, R., & Shelton, N. (2008). Health Survey for England 2007: Healthy lifestyles: Knowledge, attitudes and behaviour. Leeds: The Information Centre.
de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135–157.
Filik, R., Sipos, A., Kehoe, P. G., Burns, T., Cooper, S. J., Stevens, H., et al. (2006). The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatrica Scandinavica, 113, 298–305.
First, M. B. (Ed.). (2000). Diagnostic and statistical manual of mental disorders (4th edn)–Test Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
Gupta, A., & Craig, T. K. (2009). Diet, smoking and cardiovascular risk in schizophrenia in high and low care supported housing. Epidemiologia e psichiatria sociale, 18, 200–207.
Heatherton, T. F., Kozlowsk, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. British Journal of Addiction, 86, 1119–1127.
Henderson, L., Gregory, J., & Swan, G. (2002). National Diet and Nutrition Survey: Adults aged 19 to 64 years: Vol. 1: Types and quantities of food consumed. London: TSO.
Krakowski, M., Czobor, P., & Citrome, L. (2009). Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. Schizophrenia Research, 110, 95–102.
Kreyenbuhl, J., Medoff, D. R., Seliger, S. L., & Dixon, L. B. (2008). Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes. Schizophrenia Research, 101, 256–265.
McCreadie, R.G., On behalf of the Scottish Comorbidity Study Group. (2002). Use of drugs, alcohol and tobacco by people with schizophrenia: Case control study. British Journal of Addiction, 181, 321–325.
McCreadie, R.G., On behalf of the Scottish Schizophrenia Lifestyle Group. (2003). Diet, smoking and cardiovascular risk in people with schizophrenia: A descriptive study. British Journal of Addiction, 183, 534–539.
McCreadie, R., Macdonald, E., Blacklock, C., Tilak-Singh, D., Wiles, D., Halliday, J., et al. (1998). Dietary intake of schizophrenic patients in Nithsdale, Scotland: Case-control study. British Medical Journal, 317, 784–785.
National Institute for Clinical Excellence (NICE). (2009). Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care (update). London: NICE.
Susce, M. T., Villanueva, N., Diaz, F. J., & de Leon, J. (2005). Obesity and associated complications in patients with severe mental illnesses: A cross-sectional survey. Journal of Clinical Psychiatry, 66, 167–173.
Acknowledgments
We thank Gary Tubman, Amy Lansdown and Thomas Philips for help with data collection.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ussher, M., Doshi, R., Sampuran, A. et al. Cardiovascular Risk Factors in Patients with Schizophrenia Receiving Continuous Medical Care. Community Ment Health J 47, 688–693 (2011). https://doi.org/10.1007/s10597-011-9376-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-011-9376-y